ML
Marsh Linda
Director
BoardF
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Marsh Linda, Director. Director active across 3 companies, notably Fulgent Genetics, Inc.. In total, 14 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €8.8m. History available since 20 May 2021. The latest transaction was disclosed on 3 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Marsh Linda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
20,000 shares@ US$18.2067.3% of flowCommon StockSEC:0001104659-25-107189:0
6,449 shares0Common StockSEC:0001104659-25-059377:0
8,982 shares0Common StockSEC:0000950170-25-074718:0
11,000 shares@ US$15.35100.0% of flowCommon StockSEC:0001104659-24-099376:0
3,564 shares0Common StockSEC:0001104659-24-089699:0
8,000 shares0Common StockSEC:0000950170-24-062569:0
3,650 shares0Common StockSEC:0001104659-23-126904:0
5,059 shares0Common StockSEC:0001209191-23-031477:0
270,081 shares@ US$35.3248.7% of flowCommon StockSEC:0001628280-23-008109:0
62,500 shares@ US$10.003.2% of flowCommon StockSEC:0001250853-23-000009:0
1,600 shares0Common StockSEC:0001209191-22-044294:0
250,000 shares@ US$37.00100.0% of flowCommon StockSEC:0001104659-22-072514:0
2,000 shares0Common StockSEC:0001209191-22-030961:0
2,000 shares0Common StockSEC:0001209191-21-035452:0
About Marsh Linda
Linda Marsh is Administrateur at Fulgent Genetics, Inc., Astrana Health, Inc. and Apollo Medical Holdings, Inc. She has 14 filings in total, and across the sampled recent filings from 2021-05-24 to 2025-11-05, sales total EUR 17664794 and the most common transaction nature is Attribution.